MedWatch

Biogen partner calls for global Alzheimer's effort

Global action must be taken in the battle against Alzheimer's according to Biogen's Japanese collaborative partner Eisai, following the US pharmaceutical company's recent drug approval in the US.

Photo: Brian Snyder/Reuters/Ritzau Scanpix

Biogen's Japanese collaborative partner Eisai is calling for global action in the battle against Alzheimer's, which the partner refers to as a "secret pandemic," according to the Financial Times.

US firm Biogen recently received approval for a drug for treating Alzheimer's in the US.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs